blue

(redirected from cerulean)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

blue

1. any of a group of colours, such as that of a clear unclouded sky, that have wavelengths in the range 490--445 nanometres. Blue is the complementary colour of yellow and with red and green forms a set of primary colours
2. 
a. a sportsman who represents or has represented Oxford or Cambridge University and has the right to wear the university colour (dark blue for Oxford, light blue for Cambridge)
b. the honour of so representing one's university
3. Brit an informal name for Tory
4. any of numerous small blue-winged butterflies of the genera Lampides, Polyommatus, etc.: family Lycaenidae
5. Archery a blue ring on a target, between the red and the black, scoring five points
6. a blue ball in snooker, etc

blue

[blü]
(optics)
The hue evoked in an average observer by monochromatic radiation having a wavelength in the approximate range from 455 to 492 nanometers; however, the same sensation can be produced in a variety of other ways.

blue

in American flag, symbolizes justice. [Color Symbolism: Leach, 242; Jobes, 356]
See: Justice

Blue

A language proposed by Softech to meet the DoD Ironman requirements which led to Ada. ["On the BLUE Language Submitted to the DoD", E.W. Dijkstra, SIGPLAN Notices 13(10):10-15 (Oct 1978)].
References in periodicals archive ?
If the Dare Transaction is consummated, then under the terms of the agreement, Cerulean stockholders will hold between 30% and 49% of the combined company at closing, depending on the amount of cash each of Cerulean and Dare have at closing.
Cerulean Sky looked top class when winning the Group 1 Prix Saint-Alary at Longchamp in May, but she was unsuited by the lack of pace in the Prix de Diane and could finish only sixth to Daryaba at Chantilly.
But the French have a formidable defence led by Group 1 winners Cerulean Sky and Juvenia.
Dynamic tumor targeting company Cerulean Pharma (NasdaqGM:CERU) revealed on Monday that Dr David Parkinson, MD has joined its board of directors.
The Irish-based breeder achieved a French Group 1 double with Valentine Waltz in the Pouliches and Cerulean Sky in the Prix Saint-Alary.
Cerulean Pharma, a company that develops dynamically tumour-targeted nanopharmaceuticals, has dosed the first patient in a Phase two study of its investigational CRLX101 drug, it was reported yesterday.
Cancer treatment company Cerulean Pharma (Nasdaq:CERU) said on Tuesday that it has priced a public offering of 5,840,000 shares of its common stock.
It was reported on Friday that Cerulean Pharma, a platform-based, product-driven company that develops dynamically tumour-targeted nanopharmaceuticals, has commenced patient dosing in the Phase 2 study of CRLX101, conducted in patients with advanced gastric cancer.